Turning a scientific result into a practical application in whatever form is never a one-person or even a one-group effort. IXA can support you right from the start with finding the right partners, negotiating agreements and taking care of the formalities.
A successful collaboration agreement between researchers and external parties starts with good agreements. The legal experts and business developers at IXA can provide advice and support when drafting and recording agreements on the use of research results, and with regard to public-private partnerships.
Read more about different types of partnerships, what the objectives of partnerships could be, publication options, intellectual property rights (IP rights), market price, Anti-shelving stipulation, the ‘best-efforts obligation’ and get a general overview of various public-private partnerships:
IXA’s business developers can assist you in looking for partners with expertise, skills and facilities that suit your needs. Your own network is a good starting point, which we complement with our broad network in the public and private sectors.
Research results increasingly give rise to software. IXA has developed a checklist and flowchart for collaborating with software developers.
Negotiating an agreement that suits the interests of all parties involved can be challenging. Especially when commercial parties are involved, it is key to thoroughly prepare for discussions and negotiations. IXA gladly takes place at the table to assist you during the negotiations of any type of agreement. This way, we can ensure the interests of all parties involved are respected.
Once dialogue with a third party has started, IXA can help you to deal with the formal aspects of closing collaboration agreements. We make sure the financial, IP- and other legal aspects of the contract are fully compliant with the policies and guidelines of your institution.
LUMICKS, a spin-off of Vrije Universiteit Amsterdam, is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen […]News
On Friday November 20 State Secretary Mona Keijzer launched the national SME workshops digitization. The State Secretary for Economic Affairs and Climate talked to SME entrepreneurs and students. During the online event, Mona Keijzer launched the SME workshops by offering them to MKB Nederland. The majority of SME entrepreneurs are aware of the opportunities and […]News
The ten winners of the prestigious Academic Startup Competition 2020 can use the title ‘Best Academic Startup of 2020’ for the coming year. The winning startups were chosen by an expert jury after a thrilling final in which all 20 finalists were asked to pitch. The ten winners were chosen on the basis of their value proposition, the […]News